Dr. Vanessa Zann's headshot

Dr. Vanessa Zann

Senior Drug Development Consultant


Dr. Vanessa Zann is a Senior Drug Development Consultant at Quotient Sciences. Vanessa has over two decades of industry experience providing biopharmaceutics support to discovery, development, and clinical programs.

Since joining Quotient Sciences in 2012, she has led the implementation of modelling and simulation and has been heavily involved in pharmaceutical sciences' in-vitro characterization strategy, as well as designing clinical studies and providing scientific support through clinical study delivery.

Prior to joining Quotient Sciences, Vanessa worked at AstraZeneca as a permeability expert in the Pharmaceutical Development department. Here, she led the global Caco-2 facility for the development and was responsible for liaising with discovery scientists to ensure the selection of new chemical entities (NCEs) with appropriate biopharmaceutical properties. She introduced the intravenous (IV) microtracer technique and provided biopharmaceutical support to both discovery and development programs.

Vanessa completed postdoctoral research in buccal transport mechanisms at Cardiff University. She holds a PhD in Pharmaceutical Sciences and a Bachelor of Science in Applied and Human Biology, both from Aston University.

Hexagons with Quotient Sciences logo
Articles & Publications, Dr. Vanessa Zann

Dr. Vanessa Zann discusses biopharmaceutics with Pharmaceutical Technology

By: Dr. Vanessa Zann Read More

Latest news from Quotient Sciences

More News
News & Announcements, Dr. Vanessa Zann, artificial intelligence Outsourcing Pharma interview with Dr. Vanessa Zann By: Dr. Vanessa Zann
Read More
News & Announcements, Interviews, Thierry Van Nieuwenhove, artificial intelligence Executive interview at DCAT with Life Sciences Knowledge Hub featuring Thierry Van Nieuwenhove
Read More
Get in touch
Humanity can't afford to wait, so neither can we.